Table 1_A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.xlsx

Table 1_A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.xlsx

Introduction<p>Grade II/III gliomas are invasive brain tumors with a high risk of malignant progression and significant clinical heterogeneity, highlighting the urgent need for reliable prognostic biomarkers to guide personalized treatment strategies. This study aimed to investigate the molecu...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Hovedforfatter: Jun Mou (4113313) (author)
Andre forfattere: Min Zhang (111999) (author), Fumin Qin (21898700) (author), Yajie Cui (10289612) (author), Keyou Xu (10532345) (author), Baoye Pang (21898703) (author), Xinyue Li (628935) (author), Wanyi Tan (10589471) (author), Aiqi Yang (21898706) (author), Yaxin Liu (4163428) (author), Lingjun Shen (21898727) (author), Yanting Liu (586127) (author), Kai Xu (122914) (author)
Udgivet: 2025
Fag:
Genetic Immunology
grade II/III gliomas
mitochondrial oxidative phosphorylation
prognostic gene signature
RiskScore model
immune microenvironment
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker